 |
Several IVAC projects will be represented at ISPPD 2024 through a number of posters and oral presentations. We look forward to connecting with colleagues over the next several days.
Plenary Session 01: Equity in Pneumonia Prevention and Treatment
Monday, 18 March, 09:05–10:35, Ballroom East
Co-chaired by Dr. Laura Hammitt and Dr. Anita Shet
Parallel 03: Population Sciences and Disease Control
Monday, 18 March, 14:15–15:30, Room 1.40
Gatien de Broucker will give an oral presentation on Alleviating the Economic Burden of Pneumonia and Tackling Inequity in India.
Parallel 05: Effects of Various Pneumococcal Conjugate Vaccine Dosing Schedules on Clinical Pneumonia, Pneumococcal Carriage and IPD
Tuesday, 19 March, 14:15–15:30, Ballroom East
Julia Bennett will present on Declines in Vaccine-type IPD by Dosing Schedule in PCV10 (Synflorix) and PCV13 (Prevnar13) Childhood Immunization Programs Among Children and Older Adults Globally: The PSERENADE Project.
Poster Presentations
- Global Assessment of Childhood Pneumonia and Diarrhea Interventions: Insights from an Annual Pneumonia and Diarrhea Progress Report (Board #476)
- Translating PCV Immunization Evidence: Tools for Informed Policy-Making and Decision Support (Board #475)
- Assessment of Pneumococcal Conjugate Vaccine (PCV) Access and Coverage on VIEW-hub (Board #329)
- Introduction of the Pneumococcal Conjugate Vaccine in Humanitarian and Fragile Contexts: Perspectives from Stakeholders in Four African Countries (Board #308)
- Navigating Healthcare to Treat Pediatric Pneumonia Requiring Hospitalization in India: The Caregiver’s Perspective (Board #463)
- PCV13 Impact on Pneumococcal Carriage Among Hospitalized and Healthy Community Children in India: The PREVAIL Study (Board #398)
- Interim Analysis of PCV13 Vaccine Effectiveness Against Alveolar Consolidation Among Children Hospitalized with Pneumonia in India: The PREVAIL Study (Board #383)
- Differences in Serotype Distribution of Invasive Pneumococcal Disease Between Children <2 and 2-4 years After Long-term PCV13 Use: The PSERENADE Project (Board #039, with spotlight talk during E-Poster Spotlight 06 on Wednesday)
- Differences in Serotype Distribution of Invasive Pneumococcal Disease Among Adults Stratified by Age After Long-term Infant PCV13 Use: The PSERENADE Project (Board #373)
- Comparisons between Human Metapneumovirus (hMPV) and Respiratory Syncytial Virus (RSV) Positive Children Hospitalized with Severe Pneumonia and Community Controls: Findings from the PERCH Multi-country Study (Board #165)
- To Switch or Not to Switch: Opportunities and Country Experiences in Assessing New PCV Options to Optimize EPI Investment and Implementation (Board #478)
- Antimicrobial Susceptibility Profiles of PCV13-serotype and Non-PCV13-serotype Pneumococcal Carriage Isolates from Hospitalized Indian Children in the PREVAIL Study (e-poster #320)
- Clinical Characteristics and Outcomes Associated with Hypoxemia in Children Hospitalized with Suspected Pneumonia in India (e-poster #347)
Those not attending ISPPD this year can view related IVAC projects and resources on our website. |
|
